Synaptogenix, Inc., an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, announced that Dr. Daniel Alkon, the Company’s President and Chief Scientific Officer, will have a presentation at the Cell Symposium conference in Sitges, Spain on Tuesday, May 17th.
May 17, 2022
· 3 min read